CCL2 and Parkinson disease: Inflammatory biomarkers (SAA, CRP, IL-6, IL-8, and MCP-1) are increased in MSA compared to HCs and PD and correlate with more severe disease regarding CI (and motor symptoms), indicating an association between inflammation and a more aggressive disease course [198].